Current usage of tumor treating fields for glioblastoma

BACKGROUND: Tumor Treating Fields (TTF) have entered clinical practice for newly diagnosed and recurrent glioblastoma (GGM). However, controversies remain unresolved with regard to appropriate usage. We sought to determine TTF usage in major academic neuro-oncology programs in New York City, USA and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassman, Andrew B, Joanta-Gomez, Adela E, Pan, Peter C, Wick, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345837/
https://www.ncbi.nlm.nih.gov/pubmed/32666048
http://dx.doi.org/10.1093/noajnl/vdaa069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345837/
https://www.ncbi.nlm.nih.gov/pubmed/32666048
http://dx.doi.org/10.1093/noajnl/vdaa069

Ejemplares similares